VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ECL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ECLEcolab Inc.
$288.89$81.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksECLFinancials

Ecolab Inc. (ECL) Income Statement

30Y historyFree accessUpdated daily

Revenue growth accelerated to 9.7% in 2026Q2 with gross margin stable at 44.1%, while SG&A remained flat at $1.1B for five consecutive quarters, indicating disciplined cost control and emerging operating leverage.

Income StatementBalance SheetCash FlowRatios

ECL Income Statement

Annual statement

ECL Income Statement

Ecolab Inc. (ECL) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue16.84B16.08B15.74B15.32B14.19B12.73B11.79B12.56B14.67B13.84B13.15B13.55B14.28B13.25B11.84B6.83B6.09B5.9B6.14B5.47B4.9B4.53B4.18B3.76B3.4B2.35B2.26B2.08B1.89B1.64B1.49B
Revenue Growth %7.11%2.16%2.75%7.98%11.42%8%-6.14%-14.36%6.02%5.19%-2.9%-5.15%7.75%11.95%73.38%12.13%3.22%-3.87%12.21%11.72%7.96%8.36%11.25%10.53%44.54%3.99%8.86%10.16%15.11%10.09%11.12%
Cost of Goods Sold9.41B8.92B8.9B9.14B8.77B7.51B6.89B7.03B8.61B8.01B6.85B7.18B7.67B7.2B6.39B3.46B3.01B2.97B3.14B2.69B2.42B2.25B2.03B1.85B1.69B1.09B877.47M803.1M729.2M621.2M585.4M
COGS % of Revenue-55.49%56.53%59.68%61.8%58.99%58.46%55.99%58.69%57.87%52.08%53.01%53.72%54.3%53.99%50.7%49.42%50.35%51.19%49.21%49.35%49.59%48.59%49.05%49.58%46.27%38.75%38.61%38.62%37.87%39.29%
Gross Profit7.43B7.16B6.84B6.18B5.42B5.22B4.9B5.53B6.06B5.83B6.3B6.37B6.61B6.06B5.45B3.37B3.08B2.93B3B2.78B2.48B2.29B2.15B1.92B1.72B1.27B1.39B1.28B1.16B1.02B904.6M
Gross Margin %44.11%44.51%43.47%40.32%38.2%41.01%41.54%44.01%41.31%42.13%47.92%46.99%46.28%45.7%46.01%49.3%50.58%49.65%48.81%50.79%50.65%50.41%51.41%50.95%50.42%53.73%61.25%61.39%61.38%62.13%60.71%
Gross Profit Growth %-4.6%10.78%13.96%3.8%6.61%-11.41%-8.76%3.94%-7.52%-0.98%-3.7%9.12%11.2%61.81%9.3%5.16%-2.23%7.85%12.02%8.48%6.26%12.25%11.69%35.64%-8.78%8.61%10.17%13.72%12.67%11.16%
Operating Expenses4.5B4.25B4.23B4.02B3.81B3.54B3.19B3.62B4.08B3.63B4.3B4.38B4.59B4.28B3.92B2.44B2.26B2.18B2.26B2.09B1.87B1.74B1.66B1.43B1.32B947.48M1.06B986.9M897.1M800.7M719.2M
OpEx % of Revenue-26.4%26.88%26.22%26.86%27.78%27.04%28.82%27.8%26.24%32.66%32.35%32.13%32.29%33.12%35.71%37.06%36.93%36.78%38.23%38.16%38.45%39.6%38.12%38.79%40.24%47.01%47.45%47.51%48.81%48.27%
Selling, General & Admin4.38B4.26B4.02B3.82B3.62B3.35B3B3.43B3.86B3.43B4.11B4.19B4.39B4.09B3.74B2.34B2.17B2.09B2.17B2.01B1.79B1.68B1.6B1.43B1.28B946.09M916M852.4M775.1M699.8M629.7M
SG&A % of Revenue-26.48%25.56%24.96%25.52%26.32%25.47%27.31%26.33%24.78%31.22%30.94%30.75%30.87%31.58%34.31%35.61%35.47%35.38%36.72%36.66%36.94%38.13%38.11%37.7%40.18%40.45%40.98%41.05%42.66%42.26%
Research & Development00207M192M190M186M185M190M216M201M189M191M197M188M183M96M88M86M86M82.6M73.3M68.37M61.47M00000000
R&D % of Revenue--1.31%1.25%1.34%1.46%1.57%1.51%1.47%1.45%1.44%1.41%1.38%1.42%1.55%1.41%1.45%1.46%1.4%1.51%1.5%1.51%1.47%--------
Other Operating Expenses2.2M-12.4M000000000000000000000408K37.03M1.39M148.44M134.5M122M100.9M89.5M
Operating Income2.93B2.91B2.61B2.16B1.61B1.68B1.71B1.91B1.98B2.2B2.01B1.98B2.02B1.78B1.53B927.7M823.3M750.4M738.4M687M611.64M542.42M494.25M482.66M395.87M318.18M322.4M290M261.9M218.5M185.4M
Operating Margin %17.37%18.11%16.6%14.1%11.34%13.23%14.5%15.19%13.51%15.9%15.26%14.64%14.16%13.41%12.89%13.59%13.52%12.72%12.03%12.56%12.49%11.96%11.81%12.83%11.63%13.51%14.24%13.94%13.87%13.32%12.44%
Operating Income Growth %-11.49%20.91%34.25%-4.45%-1.47%-10.42%-3.68%-9.91%9.57%1.24%-1.91%13.71%16.51%64.47%12.68%9.71%1.63%7.48%12.32%12.76%9.75%2.4%21.92%24.42%-1.31%11.17%10.73%19.86%17.85%13.95%
EBITDA3.39B3.59B3.55B3.08B2.55B2.53B2.52B2.68B2.92B3.09B2.86B2.84B2.89B2.59B2.24B1.32B1.17B1.08B1.07B978.9M880.21M799.36M741.21M712.31M619.29M481.17M470.84M424.5M383.9M319.4M274.9M
EBITDA Margin %20.14%22.29%22.54%20.13%17.96%19.85%21.39%21.36%19.91%22.35%21.73%20.98%20.26%19.57%18.92%19.38%19.23%18.39%17.48%17.9%17.98%17.63%17.71%18.94%18.2%20.43%20.79%20.41%20.33%19.47%18.45%
EBITDA Growth %-6.62%1.05%15.03%21.04%0.81%0.21%-6.02%-8.08%-5.59%8.21%0.55%-1.77%11.55%15.78%69.28%13%7.97%1.08%9.62%11.21%10.12%7.85%4.06%15.02%28.71%2.19%10.92%10.58%20.19%16.19%15.12%
D&A (Non-Cash Add-back)457.9M672.6M935.4M923.6M938.7M843.1M812.7M775.3M938.3M893.3M850.7M859.5M872M816.2M714.5M395.7M347.9M334.3M334.7M291.9M268.57M256.94M246.95M229.66M223.43M162.99M148.44M134.5M122M100.9M89.5M
EBIT2.88B2.79B2.91B2.11B1.61B1.63B1.41B1.97B2.08B2.03B1.93B1.56B1.95B1.56B1.27B754M819.2M678.9M721.7M673.1M618.54M547.98M492.92M482.66M395.87M318.18M243.14M290M261.9M218.5M185.4M
Net Interest Income-265M-241.1M-280.6M-302.5M-255.2M-203.9M-231.5M-218.2M-259.2M-247.4M-255.4M-232.4M-243.5M-249.1M-247.7M-66.5M-65M-52.5M-61.6M-48.9M-44.42M-44.24M-45.34M00000000
Interest Income37.9M057.8M52.2M8.5M12.3M14.6M23.7M14.9M19.6M20.8M10.1M11.4M10.5M8.9M7.9M6.5M6.3M9.2M7.9M6.9M5.56M3.13M00000000
Interest Expense302.9M241.1M338.4M354.7M263.7M216.2M246.1M241.9M274.1M267M276.2M242.5M254.9M259.6M256.6M74.4M71.5M58.8M70.8M56.8M51.32M49.8M48.48M34.65M83.05M12.86M00000
Other Income/Expense-296.3M-364.7M-41.2M-405.2M-266.1M-270.3M-548.2M-177M-176.9M-437.1M-357M-665.2M-323.1M-479.4M-513.2M-248.1M-75.6M-130.3M-87.5M-70.7M-44.42M-44.24M-49.7M-34.24M-43.9M-28.43M15.65M-4.4M-5.6M800K-1.4M
Pretax Income2.63B2.55B2.57B1.76B1.34B1.41B1.16B1.73B1.8B1.76B1.65B1.32B1.7B1.3B1.01B679.6M747.7M620.1M650.9M616.3M567.22M498.18M444.55M448.42M351.97M289.75M338.05M285.6M256.3M219.3M184M
Pretax Margin %15.61%15.84%16.33%11.46%9.47%11.11%9.85%13.78%12.3%12.74%12.55%9.73%11.89%9.8%8.55%9.95%12.28%10.51%10.61%11.27%11.59%10.99%10.62%11.92%10.34%12.3%14.93%13.73%13.57%13.37%12.35%
Income Tax496.1M454.6M439.3M362.5M234.5M270.2M176.6M288.6M364.3M243.8M403.3M300.5M476.2M324.7M311.3M216.3M216.6M201.4M202.8M189.1M198.61M178.7M161.85M171.07M140.08M117.41M129.5M109.8M101.8M85.3M70.8M
Effective Tax Rate %18.87%17.84%17.09%20.65%17.46%19.11%15.21%16.67%20.19%13.83%24.44%22.8%28.04%25.01%30.74%31.83%28.97%32.48%31.16%30.68%35.01%35.87%36.41%38.15%39.8%40.52%38.31%38.45%39.72%38.9%38.48%
Net Income2.12B2.08B2.11B1.37B1.09B1.13B-1.21B1.56B1.43B1.5B1.23B1B1.2B967.8M703.6M462.5M530.3M417.3M448.1M427.2M368.62M319.48M282.69M277.35M209.77M188.17M206.13M175.8M192.5M134M113.2M
Net Margin %12.57%12.91%13.42%8.96%7.69%8.87%-10.22%12.41%9.74%10.87%9.35%7.4%8.42%7.3%5.94%6.77%8.71%7.07%7.3%7.81%7.53%7.04%6.75%7.37%6.16%7.99%9.1%8.45%10.19%8.17%7.6%
Net Income Growth %-0.92%-1.74%53.93%25.7%-3.38%193.76%-177.3%9.08%-5.02%22.36%22.7%-16.69%24.28%37.55%52.13%-12.79%27.08%-6.87%4.89%15.89%15.38%13.01%1.93%32.22%11.48%-8.71%17.25%-8.68%43.66%18.37%14.11%
Net Income (Continuing)2.13B2.09B2.13B1.39B1.11B1.14B984.8M1.44B1.44B1.52B1.25B1.02B1.22B973.6M701.3M463.3M531.1M418.7M448.1M427.2M368.62M319.48M282.69M277.35M211.89M188.17M208.56M175.8M154.5M134M113.2M
Discontinued Operations000000-2.17B133.3M178.8M0000000000000000000000
Minority Interest28.9M33.7M31.9M27.5M22.5M28.9M35M40.5M50.4M70.2M69.8M70.5M66.2M65.1M83.1M74.4M3.8M8.7M0000000000000
EPS (Diluted)7.487.287.374.793.813.91-4.205.334.885.124.143.323.933.162.351.912.231.741.801.701.431.231.091.060.750.720.780.650.720.500.42
EPS Growth %-0.53%-1.22%53.86%25.72%-2.56%193.1%-178.8%9.22%-4.69%23.67%24.7%-15.52%24.37%34.47%23.04%-14.35%28.16%-3.33%5.88%18.88%16.26%12.84%2.83%41.33%4.17%-7.69%20%-9.72%44%19.05%10.53%
EPS (Basic)-7.337.434.823.833.95-4.205.414.955.204.203.384.013.232.411.952.271.761.831.731.461.251.101.070.760.740.810.680.750.520.44
Diluted Shares Outstanding282.9M285.2M286.6M286.5M286.6M289.1M287M292.5M292.8M294M296.7M301.4M305.9M305.9M298.9M242.1M237.6M239.9M249.3M251.8M257.1M260.1M260.41M262.74M261.57M259.86M263.89M268.84M268.09M267.64M267.93M
Basic Shares Outstanding281.3M283.3M284.3M285M285.2M286.3M287M288.1M288.6M289.6M292.5M296.4M300.1M299.9M292.5M236.9M233.4M236.7M245.4M246.8M252.1M255.74M257.57M259.45M258.15M254.83M255.5M259.1M258.31M258.89M257.98M
Dividend Payout Ratio-36.31%31.45%44.98%55.22%50.13%-35.47%34.74%29.82%34.77%39.99%28.63%22.54%43.6%35.22%27.44%31.8%28.68%26.69%27.45%28.11%29.15%27.19%33.17%35.32%29.91%30.89%25.45%30.97%31.89%

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Execution risk on raised guidance

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Organic Momentum Reaccelerating

Revenue growth accelerated to 9.7% in 2026Q2 from 1.0% a year earlier, per reported figures, suggesting a broad-based recovery across industrial and institutional end markets.

The sequential acceleration from 4.8% in 2025Q4 to 9.7% in 2026Q2 indicates that pricing initiatives and volume recovery are gaining traction. Management's commentary about accelerating organic sales growth supports this trend, though the contribution from acquisitions like Ovivo Electronics remains unclear. Investors should monitor whether this pace is sustainable given the cyclicality of hospitality and industrial demand.

Gross Margin Stability Amid Mix Shifts

Gross margin held near 44% over the past year, with 2026Q2 at 44.1%, as reported in financial statements, despite raw material volatility and the drag from Ovivo Electronics.

The stability in gross margin suggests that pricing power and productivity gains are offsetting input cost inflation. However, the explicit carve-out of Ovivo Electronics from organic margin commentary implies that segment is a source of dilution. If the mix shifts toward higher-margin life sciences and institutional businesses, gross margin could expand, but this remains to be seen.

Operating Leverage Emerging

Operating income grew 6.7% sequentially in 2026Q2, outpacing the 7.3% revenue increase, as reported in the income statement, indicating modest operating leverage.

SG&A expenses remained flat at $1.1B for several quarters, while revenue climbed, allowing operating margin to expand from 15.3% in 2026Q1 to 17.2% in 2026Q2. This suggests that the field force and overhead are being utilized more efficiently. However, the absolute level of SG&A is high, and any acceleration in hiring or wage inflation could pressure margins.

EPS Quality Tempered by One-Offs

Diluted EPS of $1.90 in 2026Q2 missed consensus by $0.09, as per recent earnings release, despite a 3.3% year-over-year increase, raising questions about the quality of the beat.

The EPS miss, coupled with a raise in forward guidance, suggests that the shortfall may be timing-related or due to one-off items like Ovivo Electronics. Stock-based compensation of $34.8M in 2026Q2 is modest relative to net income, but the tax rate and non-operating items could distort underlying profitability. Investors should scrutinize the bridge between actuals and guidance in the 10-Q.

SG&A Discipline Drives Margin

SG&A has remained flat at $1.1B for five consecutive quarters, as per income statement data, while revenue grew, indicating disciplined cost control.

The flat SG&A despite revenue growth suggests that management is leveraging its existing field force and digital tools to drive productivity. However, the lack of R&D expense in most quarters is notable; if R&D is embedded in SG&A, the true investment in innovation may be understated. The recent efficiency programs may also be masking underlying cost inflation.

2025Q3 Margin Peak and EPS Dip

Operating margin peaked at 18.7% in 2025Q4, while EPS dipped 20.5% in 2025Q3, as reported in financial statements, marking a period of margin expansion but earnings volatility.

The 2025Q4 operating margin of 18.7% was the highest in the provided data, driven by strong pricing and cost controls. However, the 20.5% EPS decline in 2025Q3 suggests that non-operating items or tax effects can create significant swings. This inflection highlights the company's ability to expand margins, but also the need to look beyond headline EPS for underlying trends.

Guidance Raise Sets High Bar

The raised EPS guidance of $2.13–$2.23 for 2026Q2, per recent earnings release, implies a significant sequential acceleration that may be difficult to achieve.

The midpoint of guidance implies EPS of $2.18, which is 14.7% above the 2026Q2 actual of $1.90. This would require a substantial improvement in operating performance or a favorable tax rate. If the Ovivo Electronics drag persists or raw material costs rise, the company may miss the raised range, amplifying negative market reaction. Short-sellers could argue that the miss indicates underlying demand weakness that guidance will not overcome.

ECL — Frequently Asked Questions

Quick answers to the most common questions about buying ECL stock.

What was Ecolab Inc.'s (ECL) revenue in 2025?

For fiscal year 2025, Ecolab Inc. (ECL) reported total revenue of $16.08B. This represents a 979.3% increase compared to $1.49B in 1996.

Is Ecolab Inc. (ECL) profitable?

Ecolab Inc. (ECL) is profitable, generating $2.08B in net income for the fiscal year ending 2025 with a net profit margin of 12.9%.

What is Ecolab Inc.'s operating profit margin?

Ecolab Inc. (ECL) reported an operating income of $2.91B, resulting in an operating profit margin of 18.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Ecolab Inc.'s gross profit and gross margin?

Ecolab Inc. (ECL) generated $7.16B in gross profit for the year, representing a gross profit margin of 44.5%. This demonstrates the company's core pricing power and production efficiency.